Ahmed H Seddik

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Disease Activity

Ankylosing Spondylitis

Top Venues

PharmacoEconomics - open

The European journal of health economics : HEPAC : health economics in prevention and care

This page only lists publications with an associated author ORCID identifier.

Publications

Jeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton, Christopher J Livings, Marinus H van Hulst, Maarten Jacobus Postma, Lisa Aniek de Jong, Roel D Freriks
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland. The European journal of health economics : HEPAC : health economics in prevention and care (2023)
Ahmed H Seddik, Nima Melzer, Foteini Tsotra, Dennis A Ostwald
The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation. PharmacoEconomics - open (2021)